AN2 Therapeutics, Inc.
(NASDAQ: ANTX)
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
1.160 -
-0.030
(-2.52%)
Range
1.160 - 1.190
(2.59%)
Open
1.190
Previous Close
1.190
Bid Price
1.150
Bid Volume
2,970
Ask Price
1.160
Ask Volume
609
Volume
17,524
Value
16,888
Remark
-
Delayed prices. Updated at 30 Jan 2026 04:45.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
